FDA Approved: REGADENOSON — Original Application (Almaject, Inc.)

View source ↗

Summary

The FDA approved Almaject, Inc.'s original Abbreviated New Drug Application for regadenoson, a pharmacologic stress agent used in myocardial perfusion imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)